Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: Associations with inflammatory and cardiometabolic markers in 4391 subjects

Diabetes and Metabolism

Volumn 40, Issue 5, 2014, Pages 347-355

  Esteghamati, A ^a   Aryan, Z ^a,b   Nakhjavani, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Metabolic syndrome; Obesity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID; VITAMIN D;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLICALLY HEALTHY OBESITY; METABOLICALLY UNHEALTHY OBESITY; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; ENZYMOLOGY; INFLAMMATION; INSULIN RESISTANCE; IRAN; LIVER; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; IRAN; LIPIDS; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; VITAMIN D; WAIST CIRCUMFERENCE;

EID: 84908555474     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.02.007     Document Type: Article

References (34)

1. Esteghamati A., Meysamie A., Khalilzadeh O., Rashidi A., Haghazali M., Asgari F., et al. Third national surveillance of risk factors of non-communicable diseases (surfncd-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 2009, 9:167.
2. Eglit T., Ringmets I., Lember M. Obesity, high-molecular-weight (HMW) adiponectin, and metabolic risk factors: prevalence and gender-specific associations in Estonia. PLoS One 2013, 8:e73273.
3. Calori G., Lattuada G., Piemonti L., Garancini M.P., Ragogna F., Villa M., et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the cremona study. Diabetes Care 2011, 34:210-215.
4. Hong H.C., Lee J.S., Choi H.Y., Yang S.J., Yoo H.J., Seo J.A., et al. Liver enzymes and vitamin d levels in metabolically healthy but obese individuals: Korean national health and nutrition examination survey. Metabolism 2013.
5. Karelis A.D., Rabasa-Lhoret R. Obesity: can inflammatory status define metabolic health?. Nat Rev Endocrinol 2013, 9:694-695.
6. Autier P., Boniol M., Pizot C., Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2:76-89.
7. Khan H., Kunutsor S., Franco O.H., Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 2013, 72:89-97.
8. Ferder M., Inserra F., Manucha W., Ferder L. The world pandemic of vitamin d deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. Am J Physiol Cell Physiol 2013, 304:C1027-C1039.
9. Brenner D.R., Arora P., Garcia-Bailo B., Wolever T.M., Morrison H., El-Sohemy A., et al. Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clin Invest Med 2011, 34:E377.
10. Ding C., Gao D., Wilding J., Trayhurn P., Bing C. Vitamin d signalling in adipose tissue. Br J Nutr 2012, 108:1915-1923.
11. Lamendola C.A., Ariel D., Feldman D., Reaven G.M. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 2012, 95:1055-1059.
12. Karelis A.D., Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (mho) individuals. Diabetes Metab 2008, 34:183-184.
13. Zandieh A., Esteghamati A., Morteza A., Noshad S., Khalilzadeh O., Gouya M.M., et al. Appropriate BMI cut-off values for identification of metabolic risk factors: third national surveillance of risk factors of non-communicable diseases in Iran (surfncd-2007). Ann Hum Biol 2012, 39:484-489.
14. Esteghamati A., Ashraf H., Rashidi A., Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract 2008, 82:104-107.
15. Messier V., Karelis A.D., Prud'homme D., Primeau V., Brochu M., Rabasa-Lhoret R. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 2010, 18:911-917.
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
17. Durward C.M., Hartman T.J., Nickols-Richardson S.M. All-cause mortality risk of metabolically healthy obese individuals in nhanes iii. J Obes 2012, 2012:460321.
18. Lopez-Garcia E., Guallar-Castillon P., Leon-Munoz L., Rodriguez-Artalejo F. Prevalence and determinants of metabolically healthy obesity in Spain. Atherosclerosis 2013, 231:152-157.
19. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008, 168:1609.
20. Messier V., Karelis A.D., Robillard M.-È., Bellefeuille P., Brochu M., Lavoie J.-M., et al. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 2010, 59:20-24.
21. Muller M.J., Lagerpusch M., Enderle J., Schautz B., Heller M., Bosy-Westphal A. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev 2012, 13(Suppl. 2):6-13.
22. Karelis A.D., Faraj M., Bastard J.P., St-Pierre D.H., Brochu M., Prud'homme D., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005, 90:4145-4150.
23. Amirbaigloo A., Hosseinpanah F., Sarvghadi F., Tohidi M., Eskandary P.S., Azizi F. Absence of association between vitamin D deficiency and incident metabolic syndrome: Tehran lipid and glucose study. Metab Syndr Relat Disord 2013, 11:236-242.
24. De Pergola G., Nitti A., Bartolomeo N., Gesuita A., Giagulli V.A., Triggiani V., et al. Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients. Biomed Res Int 2013, 2013:921348.
25. Da Costa L.A., Arora P., Garcia-Bailo B., Karmali M., El-Sohemy A., Badawi A. The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults. Diabetes Metab Syndr Obes 2012, 5:347-355.
26. Samaropoulos X.F., Hairston K.G., Anderson A., Haffner S.M., Lorenzo C., Montez M., et al. A metabolically healthy obese phenotype in hispanic participants in the iras family study. Obesity (Silver Spring) 2013.
27. Bradshaw P.T., Monda K.L., Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring) 2013, 21:203-209.
28. Ismail A., Nguyen C.V., Ahene A., Fleet J.C., Uskokovic M.R., Peleg S. Effect of cellular environment on the selective activation of the vitamin d receptor by 1alpha, 25-dihydroxyvitamin d3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin d3 (ro-26-9228). Mol Endocrinol 2004, 18:874-887.
29. Neyestani T.R., Djazayery A., Shab-Bidar S., Eshraghian M.R., Kalayi A., Shariatzadeh N., et al. Vitamin d receptor fok-i polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care 2013, 36:550-556.
30. Marchesini G., Avagnina S., Barantani E., Ciccarone A., Corica F., Dall'Aglio E., et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest 2005, 28:333-339.
31. Liangpunsakul S., Chalasani N. Serum vitamin D concentrations and unexplained elevation in ALT among us adults. Dig Dis Sci 2011, 56:2124-2129.
32. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51:1889-1895.
33. Esser N., L'Homme L., De Roover A., Kohnen L., Scheen A.J., Moutschen M., et al. Obesity phenotype is related to nlrp3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia 2013, 56:2487-2497.
34. Karhapää P., Pihlajamäki J., Pörsti I., Kastarinen M., Mustonen J., Niemelä O., et al. Diverse associations of 25-hydroxyvitamin d and 1, 25-dihydroxy-vitamin d with dyslipidaemias. J Intern Med 2010, 268:604-610.